HSDT - Helius Medical Technologies, Inc. Uzoq muddatli majburiyatlarning kapitalga nisbati
Helius Medical (HSDT) rivojlanishi PoNS tizimining rehabilitatsiya standarti sifatida tan olinishi va sug'urta qoplamasini ta'minlashga bog'liq. Uzoq muddatli qarzdorlikning kapitalga nisbati dinamikasi ushbu o'zgarishlarni tasdiqlaydi, bunda 0.00 ushbu metrika uchun yangi qiymatga aylandi. Qurilmalarning energiya samaradorligiga ekologik toza yondashuv, nevrologik markazlar tarmog'ining kengayishi bilan birgalikda, kompaniyaning non-invaziv neyromodulyatsiya segmentidagi bozor mavqeini mustahkamlashga hissa qo'shmoqda.
%3A%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_HSDT_-_Helius-Medical_-_Long-Term-Debt-to-Equity-Ratio "HSDT: Helius Medical Technologies Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
HSDT (Helius Medical Technologies, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Helius Medical|HSDT - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Helius Medical Technologies Inc.|HSDT - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Helius Medical Technologies, Inc.|HSDT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Helius Medical Technologies
Kompaniyaning jamlanma tahliliyoti:heliusmedical.com
Helius Medical (HSDT) sklerozning tarqoq shaklini davolash uchun neyromodulyatsiya qurilmalarini ishlab chiqish orqali noyob nishani egallagan. Ushbu ko'rsatkich bir yildan ortiq muddatli majburiyatlarni umumiy kapitalga nisbatan bog'laydi. Investorlar yuqori texnologik ishlanmalarning moliyalashtirish barqarorligini baholash uchun ushbu balansdan foydalanadilar. Aksiyalar narxining pasayishi qarz yukini oshirish orqali xavfni avtomatik ravishda oshiradi. Uzoq muddatli qarzning kapitalga nisbati tendentsiyasi emitentning joriy moliyaviy barqarorligini aks ettiradi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|Catalyst Corp (CPRX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|DNLI - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti harmonybiosciences.com|Biohaven - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati AMLX (Amylyx Pharmaceuticals Inc)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzning o'z kapitaliga nisbati Praxis Corp PRAX|Uzoq muddatli qarzning kapitalga nisbati AVXL (Anavex Life Sciences)|ceribell.com (CBLL) - Uzoq muddatli qarzdorlikning kapitalga nisbati|PRTA: Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC (Alector) - Uzoq muddatli qarzning kapitalga nisbati|ANNX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Omeros Corp. (OMER)|Neurogene Inc. (NGNE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACIU (acimmune.com)|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Neumora NMRA|SCLX (Scilex Holding Co.) - Uzoq muddatli qarzning kapitalga nisbati|TVGN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati alphacognition.com|cogrx.com (CGTX) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|IKT: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cassava Sciences Inc|Uzoq muddatli qarzning kapitalga nisbati ASRT (Assertio Holdings, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati coyatherapeutics.com (COYA)|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Ovid Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati alteritytherapeutics.com ATHE|CLNN (Clene) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|PEPG: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati jupiterneurosciences.com|Uzoq muddatli qarzning kapitalga nisbati Relmada Therapeutics, Inc. RLMD|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Annovis Bio Inc ANVS|Uzoq muddatli qarzning o'z kapitaliga nisbati Grace Therapeutics (GRCE)|Firefly Neuro - Uzoq muddatli kreditlarning kapitalga nisbati|ANEW Medical, Inc. (KLTO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRSN - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RVPH|Uzoq muddatli majburiyatlarning kapitalga nisbati MetaVia|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati PASG|Neuphoria Therapeutics Inc. (NEUP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NERV (minervaneurosciences.com)|ATHA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Addex Therapeutics Ltd. ADXN|Uzoq muddatli qarzning kapitalga nisbati Alzamend (ALZN)|CYCN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PTIX|KTTA (Pasithea Therapeutics Corp.) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics Inc.|BCLI (Brainstorm Cell Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cara Therapeutics Inc CARA|Uzoq muddatli qarzning o'z kapitaliga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ITCI (Intra-Cellular)|Longboard Pharmaceuticals Inc (LBPH) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Marinus MRNS|NKGN (NKGen Biotech Corp) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|Uzoq muddatli qarzning o'z kapitaliga nisbati sagerx.com|Synaptogenix - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Trevena Inc. (TRVN)|VIGL - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Anew Medical Inc. WENA|Uzoq muddatli qarzning kapitalga nisbati CERE (Cerevel Therapeutics)